1-7 of 7
drug development
Close
Sort by
Journal Articles

Novel agents in follicular lymphoma: choosing the best target

Laurie H. Sehn
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 284–292.
https://doi.org/10.1182/asheducation-2016.1.284
Published: 2016
Journal Articles

Patient-reported outcomes in drug development for hematology

Catherine Acquadro, Antoine Regnault
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 496–500.
https://doi.org/10.1182/asheducation-2015.1.496
Published: 2015
Journal Articles

Accelerating safe drug development: an ideal approach to approval

Michael R. Grever
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 24–29.
https://doi.org/10.1182/asheducation-2013.1.24
Published: 2013
Journal Articles

Opening up drug development to everyone

Burt Adelman
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 311–315.
https://doi.org/10.1182/asheducation-2013.1.311
Published: 2013
Journal Articles

Drug discovery in rare indications: opportunities and challenges

Victoria M. Richon
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 19–23.
https://doi.org/10.1182/asheducation-2013.1.19
Published: 2013
Journal Articles

Anemia of Inflammation

Cindy N. Roy
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 276–280.
https://doi.org/10.1182/asheducation-2010.1.276
Published: 2010
Journal Articles

Consultations on Patients with Venous or Arterial Diseases

Barbara M. Alving, Charles W. Francis, William R. Hiatt, Mark R. Jackson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 540–558.
https://doi.org/10.1182/asheducation-2003.1.540
Published: 2003